A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia [1]

Schizophrenia Research

Volumn 76, Issue 2-3, 2005, Pages 353-356

  Fatemi, S H ^a   Stary, J M ^a   Hatsukami, D K ^a   Murphy, S E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ANXIETY; BECK DEPRESSION INVENTORY; BODY WEIGHT; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FLU LIKE SYNDROME; HAMILTON SCALE; HUMAN; INFORMED CONSENT; INSOMNIA; LETTER; NAUSEA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE;

BUPROPION; CROSS-OVER STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; HUMANS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 20444391347     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2005.02.021     Document Type: Letter

References (9)

1. G.W. Dalack, D.J. Healy, and J.H. Meador-Woodruff Nicotine dependence and schizophrenia: clinical phenomenon and laboratory findings Am. J. Psychiatry 155 1998 1490 1501
2. E.J. Douglas A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation N. Engl. J. Med. 340 1999 685 691
3. A.E. Evins, V.K. Mays, and N.A. Rigotti A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia Nicotine Tob. Res. 3 2001 397 403
4. R.J. Frances Schizophrenia and substance abuse Psychiatr. Ann. 26 1996 523 527
5. T.P. George, J.C Vessicchio, and A. Termine A placebo-controlled trial of bupropion for smoking cessation in schizophrenia Biol. Psychiatry 52 2002 53 61
6. K.E. Hayford Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism Br. J. Psychiatry 174 1999 173 178
7. A.A. Patkar, R. Gopalakrishnan, A. Lundy, F.T. Leone, K.M. Certa, and S.P. Weinstein Relationship between tobacco smoking and positive and negative symptoms in schizophrenia J. Nerv. Ment. Dis. 190 2002 604 610
8. J.E. Slemmer, B.R. Martin, and M.L. Damaj Bupropion is a nicotinic antagonist J. Pharmacol. Exp. Ther. 295 1 2000 321 327
9. E. Weiner, M.P. Ball, and A. Summerfelt Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia Am. J. Psych. 158 2001 635 637